Twitter Feed: Reuters Health

AstraZeneca, Eli Lilly, Regeneron and GlaxoSmithKline are among the biggest players to have developed COVID-19 treatments using a class of drugs called monoclonal...

• 

  Reuters Health

  AstraZeneca, Eli Lilly, Regeneron and GlaxoSmithKline are among the biggest players to have developed COVID-19 treatments using a class of drugs called monoclonal antibodies. https://t.co/hJAMYGIBnZ - view on twitter

A panel of outside advisers to the U.S. health regulator will meet late next month to discuss whether to authorize Merck & Co’s experimental...

• 

  Reuters Health

  A panel of outside advisers to the U.S. health regulator will meet late next month to discuss whether to authorize Merck & Co's experimental COVID-19 antiviral drug, the agency said on Thursday. https://t.co/RmpGdX2GI9 - view on twitter

A unit of Abbott Laboratories is recalling two COVID-19 laboratory test kits as they can potentially issue false positive results, the U.S. Food and...

• 

  Reuters Health

  A unit of Abbott Laboratories is recalling two COVID-19 test kits as they can potentially issue false positive results, the U.S. Food and Drug Administration (FDA) said on Thursday. https://t.co/V2EtEXeHQ7 - view on twitter

Bayer AG has terminated a vaccine manufacturing partnership under which it would have helped produce CureVac’s COVID-19 shot, a spokesperson for Bayer told a...

• 

  Reuters Health

  Bayer AG has terminated a vaccine manufacturing partnership under which it would have helped produce CureVac's COVID-19 shot, a spokesperson for Bayer told a German newspaper. https://t.co/IblTbntneP - view on twitter

UnitedHealth Group Inc said it expected COVID-19 to have a smaller impact on its profit next year as infections decline and more people get...

• 

  Reuters Health

  UnitedHealth Group Inc said it expected COVID-19 to have a smaller impact on its profit next year as infections decline and more people get vaccinated, sparking a rally in the shares of U.S. health insurers. https://t.co/CK6DH7ta7O - view on twitter

A panel of outside advisers to the U.S. health regulator will meet late next month to discuss whether to authorize Merck & Co’s experimental...

• 

  Reuters Health

  A panel of outside advisers to the U.S. health regulator will meet late next month to discuss whether to authorize Merck & Co's experimental COVID-19 antiviral drug, the agency said on Thursday. https://t.co/gPYaUwcF4o - view on twitter

A unit of Abbott Laboratories is recalling two COVID-19 laboratory test kits as they can potentially issue false positive results, the U.S. Food and...

• 

  Reuters Health

  A unit of Abbott Laboratories is recalling two COVID-19 laboratory test kits as they can potentially issue false positive results, the U.S. Food and Drug Administration (FDA) said on Thursday. https://t.co/INe8VDu7tR - view on twitter

Here’s what you need to know about the coronavirus right...

• 

  Reuters Health

  Here's what you need to know about the coronavirus right now: https://t.co/rEPq93oLgJ - view on twitter

Johnson & Johnson on Thursday put into bankruptcy tens of thousands of legal claims alleging its Baby Powder and other talc-based products caused cancer,...

• 

  Reuters Health

  Johnson & Johnson on Thursday put into bankruptcy tens of thousands of legal claims alleging its Baby Powder and other talc-based products caused cancer, offloading the potential liabilities into a newly created subsidiary. https://t.co/6Lws6l6Ali - view on twitter